Dr. Jack Lichtenstein, MD

NPI: 1609844224
Total Payments
$21,464
2023 Payments
$30.52
Companies
49
Transactions
1,224
Medicare Patients
2,964
Medicare Billing
$1.3M

Payment Breakdown by Category

Food & Beverage$19,441 (90.6%)
Consulting$1,850 (8.6%)
Education$172.89 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $19,441 1,216 90.6%
Consulting Fee $1,850 1 8.6%
Education $172.89 7 0.8%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $3,321 166 $0 (2022)
PFIZER INC. $3,174 86 $0 (2022)
ABBVIE INC. $2,478 190 $0 (2022)
Novartis Pharmaceuticals Corporation $1,354 90 $0 (2022)
UCB, Inc. $1,185 64 $0 (2022)
Janssen Biotech, Inc. $1,180 68 $0 (2022)
E.R. Squibb & Sons, L.L.C. $1,139 82 $0 (2021)
Lilly USA, LLC $1,059 74 $0 (2022)
Mallinckrodt Enterprises LLC $929.48 50 $0 (2019)
Horizon Therapeutics plc $628.32 58 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2023 $30.52 1 Bio Products Laboratory USA, Inc. ($30.52)
2022 $4,036 117 PFIZER INC. ($1,953)
2021 $2,850 159 Amgen Inc. ($644.84)
2020 $2,961 174 Amgen Inc. ($693.35)
2019 $3,927 265 Amgen Inc. ($450.90)
2018 $4,035 281 Amgen Inc. ($601.44)
2017 $3,624 227 AbbVie, Inc. ($493.01)

All Payment Transactions

1,224 individual payment records from CMS Open Payments — Page 1 of 49

Date Company Product Nature Form Amount Type
05/05/2023 Bio Products Laboratory USA, Inc. Gammaplex (Drug), Coagadex Food and Beverage Cash or cash equivalent $30.52 General
Category: IVIG
11/25/2022 PFIZER INC. XELJANZ (Drug) Consulting Fee Cash or cash equivalent $1,850.00 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/29/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $22.31 General
Category: IMMUNOLOGY
09/29/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $3.66 General
Category: IMMUNOLOGY
09/29/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $2.09 General
Category: IMMUNOLOGY
09/26/2022 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $7.26 General
Category: Immunology
09/22/2022 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $25.91 General
Category: Inflammation
09/21/2022 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Food and Beverage In-kind items and services $15.24 General
Category: IMMUNOLOGY
09/19/2022 PFIZER INC. XELJANZ (Drug), PAXLOVID Food and Beverage In-kind items and services $23.08 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/15/2022 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $20.81 General
Category: Immunology
09/13/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $25.65 General
Category: IMMUNOLOGY
09/12/2022 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $17.06 General
Category: Immunology
09/08/2022 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $13.91 General
Category: Immunology
09/08/2022 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Food and Beverage In-kind items and services $13.01 General
Category: Inflammation and Autoimmunity
08/30/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $14.30 General
Category: IMMUNOLOGY
08/25/2022 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $24.64 General
Category: Inflammation
08/22/2022 Amgen Inc. Tavneos (Drug) Food and Beverage In-kind items and services $14.53 General
Category: Not Applicable
08/18/2022 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $29.13 General
Category: Inflammation
08/18/2022 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $5.00 General
Category: Immunology
08/17/2022 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $15.99 General
Category: Immunology
08/16/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $21.41 General
Category: IMMUNOLOGY
08/16/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.97 General
Category: NEUROSCIENCE
08/16/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $0.39 General
Category: IMMUNOLOGY
08/12/2022 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $20.99 General
Category: Immunology
08/04/2022 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Food and Beverage In-kind items and services $14.31 General
Category: Inflammation and Autoimmunity

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 9 702 4,450 $335,711 $157,810
2021 19 1,101 11,977 $1.1M $549,606
2020 19 1,161 10,811 $1.0M $546,123
Total Patients
2,964
Total Services
27,238
Medicare Billing
$1.3M
Procedure Codes
47

All Medicare Procedures & Services

47 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 407 857 $162,830 $78,789 48.4%
J0897 Injection, denosumab, 1 mg Office 2022 40 3,180 $112,000 $53,536 47.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 75 95 $25,555 $13,510 52.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 30 30 $10,353 $4,445 42.9%
20610 Aspiration and/or injection of fluid from large joint Office 2022 28 56 $13,076 $3,351 25.6%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 18 18 $3,726 $2,056 55.2%
96372 Injection of drug or substance under skin or into muscle Office 2022 57 120 $5,520 $1,336 24.2%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2022 35 81 $1,130 $404.73 35.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 13 $1,521 $381.76 25.1%
J9312 Injection, rituximab, 10 mg Office 2021 14 2,700 $356,500 $192,544 54.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 510 1,382 $229,596 $132,030 57.5%
J1745 Injection, infliximab, excludes biosimilar, 10 mg Office 2021 12 2,373 $235,188 $80,422 34.2%
J0897 Injection, denosumab, 1 mg Office 2021 46 4,452 $126,817 $73,606 58.0%
96413 Infusion of chemotherapy into a vein up to 1 hour Office 2021 41 169 $58,040 $21,417 36.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 78 104 $24,284 $14,727 60.6%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 65 65 $20,745 $10,986 53.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 25 26 $7,389 $4,317 58.4%
96415 Infusion of chemotherapy into a vein Office 2021 28 154 $16,212 $4,204 25.9%
20610 Aspiration and/or injection of large joint or joint capsule Office 2021 32 61 $9,105 $3,598 39.5%
96401 Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle Office 2021 14 43 $4,530 $3,100 68.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 42 49 $6,437 $2,442 37.9%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 68 213 $11,210 $2,407 21.5%
96374 Injection of drug or substance into a vein for therapy, diagnosis, or prevention Office 2021 14 31 $3,162 $1,095 34.6%
20605 Aspiration and/or injection of medium joint or joint capsule Office 2021 18 23 $2,606 $1,042 40.0%
0013A Fee covid-19 vac 2 booster Office 2021 23 23 $1,440 $993.14 69.0%

About Dr. Jack Lichtenstein, MD

Dr. Jack Lichtenstein, MD is a Internal Medicine healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609844224.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Lichtenstein, MD has received a total of $21,464 in payments from pharmaceutical and medical device companies, with $30.52 received in 2023. These payments were reported across 1,224 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($19,441).

As a Medicare-enrolled provider, Lichtenstein has provided services to 2,964 Medicare beneficiaries, totaling 27,238 services with total Medicare billing of $1.3M. Data is available for 3 years (2020–2022), covering 47 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Rheumatology
  • Location Annapolis, MD
  • Active Since 03/09/2006
  • Last Updated 02/21/2008
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1609844224

Products in Payments

  • XELJANZ (Drug) $2,845
  • Enbrel (Biological) $2,312
  • COSENTYX (Biological) $1,306
  • ACTHAR (Biological) $1,285
  • Cimzia (Drug) $1,185
  • ORENCIA (Biological) $1,139
  • Humira (Biological) $1,040
  • TALTZ (Drug) $833.61
  • RINVOQ (Biological) $553.76
  • Rituxan (Biological) $420.84
  • REMICADE (Biological) $365.91
  • Otezla (Drug) $365.52
  • RAYOS (Drug) $359.97
  • SIMPONI ARIA (Biological) $341.59
  • VIMOVO (Drug) $324.08
  • TREMFYA (Drug) $303.98
  • Tymlos (Biological) $289.55
  • KEVZARA SARILUMAB INJECTION (Biological) $274.62
  • LUPKYNIS (Drug) $267.63
  • AVSOLA (Biological) $266.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Annapolis